{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:44:58Z","timestamp":1770486298378,"version":"3.49.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:00:00Z","timestamp":1517616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:00:00Z","timestamp":1517616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Female sexual dysfunction (FSD) affects as many as 1 in every 3 women, with a significant portion of these with hypoactive sexual desire disorder (HSDD). These figures alone present significant psychological and pharmacologic challenges. Partly in response to this situation, in 2015 the US Food and Drug Administration approved flibanserin for the treatment of HSDD. This approval has drawn criticism on the grounds of efficacy and necessity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To better inform potential consumers about FSD, flibanserin and other interventions for the treatment of HSDD, the importance of understanding the mechanism of FSD, and the efficacy of flibanserin and to review existing relevant knowledge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature review of extant clinic studies and theoretical discussion articles was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes<\/jats:title><jats:p>Efficacy of flibanserin for addressing symptoms associated with HSDD in premenopausal women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Extant literature and empirical evidence suggest that the efficacy of flibanserin for the treatment of HSDD in premenopausal women is at least questionable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Translation<\/jats:title><jats:p>Clinicians considering the prescription of flibanserin would be well advised to appreciate some of the controversies concerning the efficacy of the drug.<\/jats:p><\/jats:sec><jats:sec><jats:title>Strengths and Limitations<\/jats:title><jats:p>The prohibitive usage guidelines, tenuous risk-benefit profile, and considerable cost of use of flibanserin are each worthy of consideration. Flibanserin thus far has been trialed in only a narrow patient range: premenopausal women in long-term relationships with acquired or generalized HSDD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although we acknowledge that the discovery and use of flibanserin constitute a compelling narrative, we conclude by questioning the specific efficacy and necessity of flibanserin in providing a treatment for HSDD in women.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jsxm.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T23:51:47Z","timestamp":1517529107000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ignorance Is Not Bliss: If We Don\u2019t Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary"],"prefix":"10.1093","volume":"15","author":[{"given":"Ryan","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Psychology , Townsville, QLD , Australia"},{"name":"College of Healthcare Sciences , Townsville, QLD , Australia"},{"name":"James Cook University , Townsville, QLD , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire E.","family":"Moffatt","sequence":"additional","affiliation":[{"name":"Department of Psychology , Townsville, QLD , Australia"},{"name":"College of Healthcare Sciences , Townsville, QLD , Australia"},{"name":"James Cook University , Townsville, QLD , Australia"},{"name":"Neurosurgery and Neuropsychology Research Group (NNRG) , Townsville, QLD , Australia"},{"name":"James Cook University , Townsville, QLD , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"2023012309214666400_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/2040622316679933","article-title":"Flibanserin for hypoactive sexual desire disorder: place in therapy","volume":"8","author":"Gelman","year":"2017","journal-title":"Ther Adv Chron Dis"},{"key":"2023012309214666400_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/009262300278641","article-title":"The female sexual response: a different model","volume":"26","author":"Basson","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309214666400_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2015.09.050","article-title":"US food and drug administration approval of Addyi (flibanserin) for treatment of hypoactive sexual desire disorder","volume":"69","author":"Puppo","year":"2016","journal-title":"Eur Urol"},{"key":"2023012309214666400_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ca.22177","article-title":"Anatomy and physiology of the clitoris, vestibular bulbs, and labia minora with a review of the female orgasm and the prevention of female sexual dysfunction","volume":"26","author":"Puppo","year":"2013","journal-title":"Clin Anat"},{"key":"2023012309214666400_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/medethics-2014-102596","article-title":"Hypoactive sexual desire disorder: inventing a disease to sell low libido","volume":"41","author":"Meixel","year":"2015","journal-title":"J\u00a0Med Ethics"},{"key":"2023012309214666400_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bmj.c5050","article-title":"Merging of marketing and medical science","volume":"341","author":"Moynihan","year":"2010","journal-title":"BMJ"},{"key":"2023012309214666400_bib7","article-title":"Human sexual response","author":"Masters","year":"1966"},{"key":"2023012309214666400_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11930-016-0085-y","article-title":"The quest for a prosexual medication for women","volume":"8","author":"Levine","year":"2016","journal-title":"Curr Sex Health Rep"},{"key":"2023012309214666400_bib9","first-page":"S104","article-title":"Definition and classification of female sexual disorders","volume":"10","author":"Leiblum","year":"1998","journal-title":"Int J Impot Res"},{"key":"2023012309214666400_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10532528.1991.10559865","article-title":"Historical, scientific, clinical and feminist criticisms of \u201cthe human sexual response cycle\u201d model","volume":"2","author":"Tiefer","year":"1991","journal-title":"Annu Rev Sex Res"},{"key":"2023012309214666400_bib11","first-page":"116","article-title":"Endorsement of models describing sexual response of men and women with a sexual partner: an online survey in a population sample of Danish adults ages 20\u201365 years","volume":"12","author":"Giraldi","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib12","first-page":"S94","article-title":"Psychophysiological models of female sexual response","volume":"10","author":"Heiman","year":"1988","journal-title":"Int J Impot Res"},{"key":"2023012309214666400_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0005-7967(80)90107-2","article-title":"Effects of erotic stimuli on sexually functional and dysfunctional women: multiple measures before and after sex therapy","volume":"18","author":"Morokoff","year":"1980","journal-title":"Behav Res Ther"},{"key":"2023012309214666400_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1469-8986.1995.tb02095.x","article-title":"Determinants of subjective experience of sexual arousal in women: feedback from genital arousal and erotic stimulus content","volume":"32","author":"Laan","year":"1995","journal-title":"Psychophysiology"},{"key":"2023012309214666400_bib15","first-page":"2095","article-title":"Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis","volume":"12","author":"Gao","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ebiom.2015.08.009","article-title":"Flibanserin for low sexual desire in women: a molecule from bench to bed?","volume":"2","author":"Basson","year":"2015","journal-title":"Ebiomedicine"},{"key":"2023012309214666400_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamainternmed.2016.0073","article-title":"US Food and Drug Administration approval of flibanserin: Even the Score does not add up","volume":"176","author":"Woloshin","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2023012309214666400_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jama.2015.8405","article-title":"Evaluation of flibanserin: science and advocacy at the FDA","volume":"314","author":"Gellad","year":"2015","journal-title":"JAMA"},{"key":"2023012309214666400_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2023012309214666400_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"2023012309214666400_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1464-410X.2008.07453.x","article-title":"Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe","volume":"101","author":"Moreira","year":"2008","journal-title":"BJU Int"},{"key":"2023012309214666400_bib22","first-page":"777","article-title":"What is the \u201ctrue\u201d prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?","volume":"5","author":"Hayes","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.168.13.1441","article-title":"Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women","volume":"168","author":"West","year":"2008","journal-title":"Arch Intern Med"},{"key":"2023012309214666400_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/gme.0b013e318230e286","article-title":"Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women","volume":"19","author":"Rosen","year":"2012","journal-title":"Menopause"},{"key":"2023012309214666400_bib25","first-page":"212","article-title":"Hypoactive sexual desire disorder in menopausal women: a survey of Western European women","volume":"2","author":"Dennerstein","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10508-013-0107-z","article-title":"Prevalence of women\u2019s sexual desire problems: what criteria do we use?","volume":"42","author":"McCabe","year":"2013","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib27","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"2023012309214666400_bib28","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"2023012309214666400_bib29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10508-013-0247-1","article-title":"Female sexual interest\/arousal disorder: a diagnosis out of thin air","volume":"43","author":"Balon","year":"2014","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10508-013-0248-0","article-title":"Response to Balon and Clayton (2014): Female sexual interest\/arousal disorder is a diagnosis more on firm ground than thin air","volume":"43","author":"Graham","year":"2014","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib31","first-page":"639","article-title":"Flibanserin: a potential treatment for hypoactive sexual desire disorder in premenopausal women","volume":"6","author":"Clayton","year":"2010","journal-title":"Womens Health"},{"key":"2023012309214666400_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852914000832","article-title":"Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder","volume":"20","author":"Stahl","year":"2015","journal-title":"CNS Spectr"},{"key":"2023012309214666400_bib33","first-page":"337","article-title":"Recommendations for the clinical evaluation of men and women with sexual dysfunction","volume":"7","author":"Hatzichristou","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/AOG.0b013e31821921ce","article-title":"Female sexual dysfunction. ACOG Practice Bulletin No. 119","volume":"117","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2023012309214666400_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000134","article-title":"Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"2023012309214666400_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40264-015-0389-2","article-title":"Maximizing the post-approval safety of flibanserin: a role for regulators, clinicians, and patients","volume":"39","author":"Baksh","year":"2016","journal-title":"Drug Saf"},{"key":"2023012309214666400_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10508-009-9543-1","article-title":"The DSM diagnostic criteria for hypoactive sexual desire disorder in women","volume":"39","author":"Brotto","year":"2010","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10508-015-0643-9","article-title":"Flibanserin","volume":"44","author":"Brotto","year":"2015","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp1513686","article-title":"FDA approval of flibanserin-treating hypoactive sexual desire disorder","volume":"374","author":"Joffe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"2023012309214666400_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/0092623X.2017.1280865","article-title":"Is flibanserin meaningfully superior to placebo?","volume":"43","author":"Clayton","year":"2017","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309214666400_bib41","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s10508-015-0617-y","article-title":"Flibanserin","volume":"44","author":"Levine","year":"2015","journal-title":"Arch Sex Behav"},{"key":"2023012309214666400_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamainternmed.2015.8565","article-title":"Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis","volume":"176","author":"Jaspers","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2023012309214666400_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/edrv.22.3.0430","article-title":"Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment","volume":"22","author":"Kandeel","year":"2001","journal-title":"Endocr Rev"},{"key":"2023012309214666400_bib44","first-page":"15","article-title":"Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder","volume":"8","author":"Stahl","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Res"},{"key":"2023012309214666400_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.embor.7401008","article-title":"Linking emotion to the social brain","volume":"8","author":"Lesch","year":"2007","journal-title":"EMBO Rep"},{"key":"2023012309214666400_bib47","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","article-title":"Dopamine receptors and brain function","volume":"35","author":"Jaber","year":"1996","journal-title":"Neuropharmacology"},{"key":"2023012309214666400_bib48","article-title":"Viagra for women gets push for FDA approval","author":"Pollack"},{"key":"2023012309214666400_bib49","article-title":"Aid to women, or bottom line? Advocates split on libido pill","author":"Tavernise"},{"key":"2023012309214666400_bib50","article-title":"Addyi (Flibanserin) tablets, for oral use: US prescribing information","author":"Sprout Pharmaceuticals Inc"},{"key":"2023012309214666400_bib51","first-page":"20","article-title":"Efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder","volume":"6","author":"Goldfischer","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib52","first-page":"3180","article-title":"Open-label extension study of flibanserin in women with hypoactive sexual desire disorder","volume":"9","author":"Jayne","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib53","first-page":"1074","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study","volume":"9","author":"DeRogatis","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib54","first-page":"793","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study","volume":"9","author":"Thorp","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib55","first-page":"1807","article-title":"Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial","volume":"10","author":"Katz","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib56","first-page":"834","article-title":"Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study","volume":"14","author":"Portman","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib57","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016\u2013103473","article-title":"The unethical use of ethical rhetoric: the case of flibanserin and pharmacologisation of female sexual desire","author":"Cha\u0144ska","year":"2016","journal-title":"J\u00a0Med Ethics"},{"key":"2023012309214666400_bib58","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/jcpt.12563","article-title":"The pharmacodynamic effects of combined administration of flibanserin and alcohol","volume":"42","author":"Stevens","year":"2017","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"2023012309214666400_bib59","article-title":"The FDA is set to approve the \u201cfemale Viagra\u201d. Critics say it\u2019s a mistake","author":"Belluz"},{"key":"2023012309214666400_bib60","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon","year":"2005","journal-title":"J\u00a0Clin Endocr Metab"},{"key":"2023012309214666400_bib61","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.gme.0000243567.32828.99","article-title":"Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study","volume":"13","author":"Shifren","year":"2006","journal-title":"Menopause"},{"key":"2023012309214666400_bib62","first-page":"1134","article-title":"Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women","volume":"9","author":"Davis","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib63","first-page":"824","article-title":"Toward personalized sexual medicine (part 3): testosterone combined with a serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms","volume":"10","author":"van Rooij","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib64","first-page":"810","article-title":"Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues","volume":"10","author":"Poels","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib65","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: an Endocrine Society clinical practice guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J\u00a0Clin Endocr Metab"},{"key":"2023012309214666400_bib66","first-page":"1223","article-title":"Commentary: are the Endocrine Society\u2019s clinical practice guidelines on androgen therapy in women misguided? A commentary","volume":"4","author":"Traish","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.maturitas.2015.09.008","article-title":"Flibanserin for postmenopausal women\u2014are they really that different?","volume":"82","author":"Simon","year":"2015","journal-title":"Maturitas"},{"key":"2023012309214666400_bib68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial","volume":"105","author":"Buster","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2023012309214666400_bib69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","article-title":"Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"13","author":"Davis","year":"2006","journal-title":"Menopause"},{"key":"2023012309214666400_bib70","first-page":"859","article-title":"Reviews: management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies","volume":"4","author":"Braunstein","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"2023012309214666400_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02853164","article-title":"Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women","volume":"17","author":"Waynberg","year":"2000","journal-title":"Adv Ther"},{"key":"2023012309214666400_bib72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2008-2231-22-40","article-title":"Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo-controlled study","volume":"22","author":"Akhtari","year":"2014","journal-title":"DARU"},{"key":"2023012309214666400_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00926230600834901","article-title":"The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status","volume":"32","author":"Ito","year":"2006","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023012309214666400_bib74","first-page":"2451","article-title":"Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective","volume":"12","author":"Pyke","year":"2015","journal-title":"J\u00a0Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518300316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518300316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/3\/273\/48587302\/jsm_15_3_273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/3\/273\/48587302\/jsm_15_3_273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:33:20Z","timestamp":1751286800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/15\/3\/273\/6980275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,3]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.01.001","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,2,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ignorance Is Not Bliss: If We Don\u2019t Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}